04/11/2024
7:30 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2024
7:32 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:15 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:12 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:14 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:08 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:09 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/06/2024
11:40 AM | Arcutis Biotherapeutics (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
| Form SC 13D/A | |
03/06/2024
9:31 AM | Arcutis Biotherapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G/A | |
03/04/2024
4:44 PM | Arcutis Biotherapeutics (Subject)
OSBORNE DAVID W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:47 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:38 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:40 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:42 PM | Arcutis Biotherapeutics (Subject)
Moore Matthew Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:21 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
02/27/2024
3:34 PM | Arcutis Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:48 AM | Arcutis Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:44 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
5:36 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:47 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:23 PM | Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:30 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:32 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:19 PM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I/A | |
02/15/2024
3:20 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
11:29 AM | Arcutis Biotherapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
8:26 AM | Arcutis Biotherapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
02/12/2024
8:52 AM | Arcutis Biotherapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G | |
02/12/2024
5:06 AM | Arcutis Biotherapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G | |
02/08/2024
11:15 PM | Arcutis Biotherapeutics (Filer)
| Form EFFECT | |
02/08/2024
11:52 AM | Arcutis Biotherapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G | |
01/31/2024
4:22 PM | Arcutis Biotherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/29/2024
2:26 PM | Arcutis Biotherapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/23/2024
9:26 AM | Arcutis Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/17/2024
3:28 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:30 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:32 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:34 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:35 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:03 AM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I | |
01/03/2024
4:30 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad) “Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him |
01/02/2024
1:29 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
4:24 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
2:26 PM | Arcutis Biotherapeutics (Subject)
Turney Patricia A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
5:33 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
7:51 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
2:51 PM | Arcutis Biotherapeutics (Subject)
Burrows Scott L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
4:47 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
2:36 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
12:13 PM | Arcutis Biotherapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G | |
11/13/2023
8:02 AM | Arcutis Biotherapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/09/2023
1:54 PM | Arcutis Biotherapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G | |
11/07/2023
2:33 PM | Arcutis Biotherapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
11/03/2023
6:32 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
6:36 AM | Arcutis Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2023
3:23 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
10/23/2023
3:25 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
3:02 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
3:15 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
10/03/2023
8:45 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
8:41 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/27/2023
3:30 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
3:07 PM | Arcutis Biotherapeutics (Filer)
| Form 10-K/A | |
09/15/2023
3:08 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q/A | |
09/15/2023
3:09 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q/A | |
09/12/2023
6:39 AM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
5:48 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K/A | |
09/05/2023
8:36 PM | Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2023
8:38 PM | Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
11:24 AM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
9:58 AM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023
3:32 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
3:31 PM | Arcutis Biotherapeutics (Subject)
Lock Kenneth A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
4:22 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
8:36 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
7:31 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:16 PM | Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:22 PM | Arcutis Biotherapeutics (Issuer)
LIN SUE-JEAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
5:54 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
5:59 PM | Arcutis Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:02 PM | Arcutis Biotherapeutics (Issuer)
Leonard Keith R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:08 PM | Arcutis Biotherapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:10 PM | Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:13 PM | Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
2:25 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2023
4:03 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
